Kashyap Patel, MD, immediate past president of Community Oncology Alliance (COA) and CEO of Carolina Blood and Cancer Care Associates, talks about bringing together different stakeholders in the oncology space in order to benefit patients and providers.
Kashyap Patel, MD, gives a preview of what Community Oncology Alliance (COA) will be focusing on at the 2023 Community Oncology Conference.
Transcript
What are you looking forward to at the 2023 Community Oncology Conference?
This year's COA meeting is going to focus on multiple issues of public interest, beginning from what's happening in the 340B space, what COA is doing in a congressional effort to address the PBMs (pharmacy benefit managers). Because we all understand that the US health care space is quite complicated, with multiple factors beginning from the state, the local, the commercial payer, the Medicare Advantage plans, the MCO (Multi-Criteria Optimization). So all of this makes the space very complicated, and combine that with 340B and health care equity issues.
COA's effort is to try to bring the stakeholders from multiple areas—from the payer space to the provider space to the pharma space—to bring almost like a coalition of like-minded people together that combines the science, the ethics, morality, public policy, and the steps that COA has been taking to ensure that we remain constantly engaged and share information, of COA's bold and widespread effort, beginning from Congress to state level, to ensure that we extend the cause which is advocating for committee oncology policies and patients. We remain united in our efforts to be spokespersons for patients and the providers. In the same token, we also take the leap of ensuring that access to care—which is provided at multiple practices in a smaller rural area, where if we disappear, there will be no access—stays as what it is.
Tackling Health Inequality: The Power of Education and Experience
April 30th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our final episode of this limited series and our conversation with Janine Jelks-Seale, MSPPM, director of health equity at UPMC Health Plan.
Listen
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Specialty Pharmacists at the Forefront: Elevating Care for Rare Diseases
May 1st 2024In the US, a disease is considered rare when it affects fewer than 200,000 persons, or 1 in every 1500 individuals, with an estimated total of 25 to 30 million Americans overall living with a rare disease at any given time.
Read More
Joanne Mizell: Lifestyle Modification Programs Take Holistic Aim at Metabolic Disease
May 1st 2024Joanne Mizell shares insurer strategies in addressing the escalating rates of metabolic diseases, highlighting the importance of holistic treatment methods like lifestyle modification programs, which integrate nutrition, physical activity, and community engagement.
Read More